New potentialities in postoperative analgesia

E. Yu. Khalikova; T. M. Alexeeva; I. V. Lapkina

doi:10.17816/RA36158

Regional Anesthesia and Acute Pain Management ›› 2012, Vol. 6 ›› Issue (2) : 62 -66. DOI: 10.17816/RA36158

Articles

research-article

New potentialities in postoperative analgesia

Author information +

History +

PDF

Abstract

Cite this article

Download citation ▾

E. Yu. Khalikova, T. M. Alexeeva, I. V. Lapkina. New potentialities in postoperative analgesia. Regional Anesthesia and Acute Pain Management, 2012, 6(2): 62-66 DOI:10.17816/RA36158

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Acute Pain Management: Scientific Evidence. Australian and New Zeland College of Anaesthetists, 2-nd edition, 2005 (endorsed Royal College of Anaesthetists, UK) - 310S.

[2]	Acute Pain Management: Scientific Evidence. Australian and New Zeland College of Anaesthetists and Faculty of Pain Medicine, 3-rd edition, 2010; 491S.

[3]	Apfelbaum J.L. et al. Anesth. Analg. 2003; 97: 534-540.

[4]	Barbanoj M.J., Antonijoan R.M. et al. Clinical pharmacokinetics of dexketoprofen // Clin. Pharmacokinet. 2001; 40(4): 245-262.

[5]	Debré F., Zapata A. et al. The analgesic efficacy of dexketoprofen trometamol i. v. in renal colic: a double-blind randomised, active, controlled trial versus ketoprofen. 10th World Congress on Pain, IASP, San Diego, California.

[6]	European Minimum Standards for the Management of Postoperative Pain - 1998.

[7]	Green G.A. Understanding NSAIDs: from aspirin to COX-2 // Clin. Cornerstone. 2001; 3(5): 50-60.

[8]	Herrero J.F., Romero-Sandoval E.A. et al. Antinociception and the new COX inhibitors: research approaches and clinical perspectives // CNS Drug Rev. 2003; 9(3): 227-252.

[9]	Jamali F., Brocks D.R. Clinical pharmacokinetics of ketoprofen and its enantiomers // Clin. Pharmacokinet. 1990; 19(3): 197217.

[10]	Laporte J.R., Ibanez L. et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents // Drug Saf. 2004; 27(6): 411-420.

[11]	Leman P., Kapadia Y. et al. Randomised controlled trial of the onset of analgesic efficacy of dexketoprofen and diclofenac in lower limb injury // Emerg. Med. J. 2003; 20(6): 511-513.

[12]	Lopez-Munoz F.J., Ventura R. et al. Antinociceptive effects of S(+)-ketoprofen and other analgesic drugs in a rat model of pain induced by uric acid // J. Clin. Pharmacol. 1998; 38(12 Suppl): 11S-21S.

[13]	Marenco J., Pérez M. et al. A multicentre, randomised, doubleblind study to compare the efficacy and tolerability of dexketoprofen trometamol versus diclofenac in symptomatic treatment of knee ostearthritis // Clin. Drug Invest. 2000; 19: 247-256.

[14]	Mauleon D., Artigas R. et al. Preclinical and clinical development of dexketoprofen // Drugs. 1996; 52 (Suppl 5): 24-45; discussion 45-46.

[15]	Mazario J., Roza C. et al. The NSAID dexketoprofen trometamol is as potent as mu-opioids in the depression of wind-up and spinal cord nociceptive reflexes in normal rats // Brain Res. 1999; 816(2): 512-517.

[16]	McGurk M., Robinson P. et al. Clinical comparison of dexketoprofen trometamol, ketoprofen, and placebo in postoperative dental pain // J. Clin. Pharmacol. 1998; 38(12 Suppl): 46S-54S.

[17]	Metscher B., Kubler U. et al. Dexketoprofen-trometamol and tramadol in acute lumbago // Fortschr Med. Orig. 2000; 118(4): 147-151.

[18]	Moore R. Andrew, Jodie Barden. Systematic review of dexketoprofen in acute and chronic pain // BMC Clinical Pharmacology. 2008.

[19]	Vallés J., Artigas R. et al. Pharmacokinetics of dexketoprofen trometamol in subjects with mild and moderate chronic renal insufficiency // Methods Find Exp. Clin. Pharmacol. 2006; 28 (Suppl A): 21-28.